Agende la participación del Colegio Argentino de Cardioangiólogos Intervencionistas en el Congreso TCT 2018.
CACI – TCT 2018
Sunday, 23rd September 2018 • 2:00-3:30 pm
25A-B, Upper Level
PCI in Stable angina patients after ORBITA: Why is it not the last nail for coronary angioplasty?
CACI -TCT 2018 Partnership
Chairman: Aníbal Damonte, MD; Diego Grinfeld, MD; Alfredo E Rodríguez MD,PhD
2:00 – 2:03 Introduction & Session Objectives. Aníbal Damont, MD(sacar el MD que quedó al principio de la oración)
2:03 – 2:13 Role of PCI in Stable angina patients. Roxana Merhan, MD
2:13 – 2:18 Discussion.
2:18 – 2:23 Clinical Case Presentation. Guillermo Migliaro, MD
2:23 – 2:26 Case Discussion
2:26 – 2:36 Clinical Implications of the ORBITA trial if any? John Ambrose, MD
2:36 – 2:41 Discussion
2:41 – 2:46 Clinical Case Presentation. Rubén Piraino, MD
2:46 – 2:49 Case Discussion
2:49 – 2:59 SCAI statements on the role of PCI in stable angina after ORBITA. David Cox, MD
2:59 – 3:04 Discussion
3:04 – 3:09 Clinical Case Presentation. Antonio Pocoví, MD
3:09 – 3:12 Case Discussion.
3:12 – 3: 22 Q&A with panelists and audience. Jorge Leguizamón, MD; Miguel Ballarino, MD; Omar Santaera, MD.
3:22 – 3:30 Session Summary and Closing Remarks. Alfredo E Rodriguez, MD, PhD
Monday, Sept 24 • 1:30 PM-3:30 PM
Room 24C
International Session: Hemodynamic functional assessment of coronary stenosis in daily practice
Presented by Groupe Atherome et Cardiologie Interventionnelle (GACI) and Colegio Argentino de Cardioangiólogos Intervencionistas (CACI)
Moderators: Anibal Damonte, MD; Jacques Monségu, MD
Discussants: Diego Grinfeld, MD; Alejandro Cherro, MD; Brahim Harbaoui, MD; Alejandro Palacios, MD; Ernesto Torresani, MD; Antoine Py, MD.
1:30 – 1:35 Introduction Anibal Damonte, MD
1:35 – 1:48 How to perform an hemodynamic functional assessment and its pitfalls? Raúl Solernó, MD
1:48 – 2:01 Controversy between FFR and iFR
Pro FFR: Daniel Berrocal, MD
2:01 – 2:14
Pro iFR: Jacques Monsegu, MD
2:14 – 2:29 Discussion
2:29 – 2:42 PM Multi vessel disease: is invasive physiology a good tool to change my strategy? Eric Van Belle, MD
2:42 – 2:55 How to deal invasive physiology in left main disease? Leandro Lasave, MD
2:55 – 3:08 Is there a place to invasive physiology in acute coronary syndrome? Patrick Dupouy, MD
3:08 – 3:24 Discussion
3:24 – 3:30 Conclusion. Jacques Monségu, MD
